AF
SPRB

Amalgamated Financial’s Spruce Biosciences SPRB Stock Holding History

Amalgamated Financial’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2K Buy
+14
New +$2.6K ﹤0.01% 2988

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Amalgamated Financial's SPRB Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Spruce Biosciences (SPRB) in Q1 2022: 14 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #2988 among its holdings.

43 funds tracked by Wall St. Rank hold SPRB as of Q1 2022.

  • Amalgamated Financial held 14 shares of Spruce Biosciences worth $2K as of Q1 2022.
  • Spruce Biosciences was a new Amalgamated Financial position in Q1 2022.
  • Spruce Biosciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2988 holding.
  • 43 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.